# Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy

> **NCT04376528** · PHASE4 · UNKNOWN · sponsor: **West China Hospital** · enrollment: 89 (estimated)

## Conditions studied

- Hepatitis, Autoimmune
- Primary Biliary Cholangitis
- Immunosuppression

## Interventions

- **DRUG:** Cyclosporin A
- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT04376528
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-16
- **Primary completion:** 2021-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 89 (ESTIMATED)
- **Last updated:** 2021-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04376528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04376528, "Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04376528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*